As a member of EFPIA (European Federation of Pharmaceutical Industries and Associations) and ARPharM (The Association of the Research-based Pharmaceutical Manufacturer in Bulgaria) we are fostering the transparency on the interaction between the pharmaceutical industry and health care professionals & organisations according EFPIA, as well as all national legal regulations, as we are convinced to be independent partners with the same goal: cooperation and exchange of knowledge, as well as research and development without tortious interference or influence.
Donations and grants to HCO, HCP’s organisations and associations, organisations providing healthcare;
Costs related to Events: registration fees, sponsorship agreements, travel and accommodation;
Fees for Service and Consultancy to HCPs and HCOs: fees and related expenses must be disclosed separately. This is only applicable, when the HCPs or HCOs have provided their consent on the individual disclosure, otherwise the data needs to be published in the aggregated disclosure data
R&D costs: including costs for related events (investigators’ meetings, etc);
Transfers of value which cannot be disclosed on an individual basis for legal reasons
Disclaimer: Publication of transfers of value to Recipients aims at reporting the values (monetary or in-kind) to HCPs/HCOs our company is collaborating / has relationships with, following the objectives and provisions included in the applicable codes. Individual disclosures have been consented to by individual Recipients – such consent has been given to allow complying with the applicable codes that our company signed off to. These publications do not grant a general permission for those accessing our website or the national platforms to undertake additional processing of the healthcare professionals’ data.
For a good understanding of the reporting included in our disclosures as published on this website, we refer to the Methodological Note that clarifies the meaning and content of the transfers of value reported.
For more questions on the EFPIA code or concerning a disclaimer or revocation of your consent to the individual disclosure, do not hesitate to contact uson the EFPIA code or concerning a disclaimer or revocation of your consent to the individual disclosure, do not hesitate to contact us.